Protein Purification Using Displacement Chromatography
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/636,511, filed Apr 20, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,683,033 | Cell Culture Methods to Reduce Acidic Species In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,957,318 | Protein Purification Methods to Reduce Acidic Species In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,181,572 | Methods to Modulate Lysine Variant Distribution In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,193,787 | Human Antibodies That Bind Human Tnf-Alpha and Methods of Preparing the Same In force · Medium confidence | AbbVie, Inc. | In force | Medium confidence | ||
| US 9,334,319 | Low Acidic Species Compositions In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,346,879 | Protein Purification Methods to Reduce Acidic Species In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,359,434 | Cell Culture Methods to Reduce Acidic Species In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,505,833 | Human Antibodies That Bind Human Tnf-Alpha and Methods of Preparing the Same In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,708,399 | Protein Purification Using Displacement Chromatography In force · Medium confidence | AbbVie, Inc. | In force | Medium confidence | ||
| US 9,708,400 | Methods to Modulate Lysine Variant Distribution In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| 9 more patents in this group · Pro | ||||||
10 of 19 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 19.
12 of these are in force and held by AbbVie Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.